Phase I-II Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer.

Trial Profile

Phase I-II Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Oct 2011

At a glance

  • Drugs Capecitabine; Oxaliplatin
  • Indications Cholangiocarcinoma; Colorectal cancer; Gallbladder cancer; Gastric cancer; Pancreatic cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CORGI
  • Most Recent Events

    • 25 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top